These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 20456739)
1. Comparing the cumulative incidences of add-on therapy among the major antihypertensive classes in 2531 Asian patients: a cohort study. Wong MC J Clin Pharm Ther; 2010 Apr; 35(2):201-5. PubMed ID: 20456739 [TBL] [Abstract][Full Text] [Related]
2. Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. Wong MC J Hum Hypertens; 2008 Jun; 22(6):435-7. PubMed ID: 18322547 [TBL] [Abstract][Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N; Martins S; Belo A; Fiuza M; Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [TBL] [Abstract][Full Text] [Related]
7. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study. Wong MC; Lau RK; Jiang JY; Griffiths SM J Clin Pharm Ther; 2012 Jun; 37(3):335-41. PubMed ID: 22023456 [TBL] [Abstract][Full Text] [Related]
8. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094 [TBL] [Abstract][Full Text] [Related]
9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [TBL] [Abstract][Full Text] [Related]
10. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Van Wijk BL; Klungel OH; Heerdink ER; de Boer A Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
12. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes. Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drug-associated sexual dysfunction: a prescription analysis-based study. al Khaja KA; Sequeira RP; al Damanhori AH; Mathur VS Pharmacoepidemiol Drug Saf; 2003; 12(3):203-12. PubMed ID: 12733473 [TBL] [Abstract][Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
16. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Itskovitz HD Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316 [TBL] [Abstract][Full Text] [Related]
17. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents. Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574 [TBL] [Abstract][Full Text] [Related]
18. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240 [TBL] [Abstract][Full Text] [Related]